Antibody tests for identification of current and past infection with SARS‐CoV‐2

T Fox, J Geppert, J Dinnes, K Scandrett… - Cochrane database …, 2022‏ - cochranelibrary.com
Background The diagnostic challenges associated with the COVID‐19 pandemic resulted in
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …

Advanced point‐of‐care testing technologies for human acute respiratory virus detection

Z Zhang, P Ma, R Ahmed, J Wang, D Akin… - Advanced …, 2022‏ - Wiley Online Library
The ever‐growing global threats to human life caused by the human acute respiratory virus
(RV) infections have cost billions of lives, created a significant economic burden, and …

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

KS Corbett, DK Edwards, SR Leist, OM Abiona… - Nature, 2020‏ - nature.com
A vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is needed to
control the coronavirus disease 2019 (COVID-19) global pandemic. Structural studies have …

[HTML][HTML] Oriented immobilization of antibodies onto sensing platforms-A critical review

S Gao, JM Guisán, J Rocha-Martin - Analytica chimica acta, 2022‏ - Elsevier
The immunosensor has been proven a versatile tool to detect various analytes, such as food
contaminants, pathogenic bacteria, antibiotics and biomarkers related to cancer. To fabricate …

Emerging ELISA derived technologies for in vitro diagnostics

P Peng, C Liu, Z Li, Z Xue, P Mao, J Hu, F Xu… - TrAC Trends in …, 2022‏ - Elsevier
ELISA technology has received great attention in in vitro diagnostics (IVD) due to its high
specificity, sensitivity and high throughput. However, the traditional ELISA technology is …

Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of children

Q Xu, P Milanez-Almeida, AJ Martins, AJ Radtke… - Nature …, 2023‏ - nature.com
Most studies of adaptive immunity to SARS-CoV-2 infection focus on peripheral blood, which
may not fully reflect immune responses at the site of infection. Using samples from 110 …

Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal betacoronaviruses

J Hicks, C Klumpp-Thomas, H Kalish… - Journal of clinical …, 2021‏ - Springer
In order to properly understand the spread of SARS-CoV-2 infection and development of
humoral immunity, researchers have evaluated the presence of serum antibodies of people …

Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States

H Kalish, C Klumpp-Thomas, S Hunsberger… - Science translational …, 2021‏ - science.org
Asymptomatic SARS-CoV-2 infection and delayed implementation of diagnostics have led to
poorly defined viral prevalence rates in the United States and elsewhere. To address this …

Identification of resident memory CD8+ T cells with functional specificity for SARS-CoV-2 in unexposed oropharyngeal lymphoid tissue

J Niessl, T Sekine, J Lange, V Konya, M Forkel… - Science …, 2021‏ - science.org
Cross-reactive CD4+ T cells that recognize severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) are more commonly detected in the peripheral blood of unexposed …

The Omicron variant BA. 1.1 presents a lower pathogenicity than B. 1 D614G and Delta variants in a feline model of SARS-CoV-2 infection

M Martins, GM do Nascimento, M Nooruzzaman… - Journal of …, 2022‏ - journals.asm.org
ABSTRACT Omicron (B. 1.1. 529) is the most recent SARS-CoV-2 variant of concern, which
emerged in late 2021 and rapidly achieved global predominance by early 2022. In this …